Recombinant ESR1 refers to engineered forms of the estrogen receptor alpha (ERα) produced in heterologous expression systems (e.g., baculovirus, mammalian cells). These proteins are critical for studying ER signaling, ligand interactions, and drug development.
Pagrus major (red seabream) is a marine teleost fish, and while ESR1 homologs exist in fish species, no peer-reviewed studies or commercial products specifically describe a recombinant partial ESR1 protein from this organism.
Evolutionary Conservation:
Fish ESR1 retains structural homology with mammalian ESR1, particularly in the DNA- and ligand-binding domains[^general].
Functional roles in vitellogenesis and reproductive cycling are well-documented in model fish (e.g., zebrafish, medaka)[^general].
Recombinant Fish ESR1 Challenges:
Partial ESR1 constructs (e.g., LBD-only) are often used to study ligand specificity but require species-specific optimization.
No Pagrus major ESR1 sequences or expression protocols are cataloged in major protein databases (e.g., UniProt, NCBI Protein).
To develop "Recombinant Pagrus major ESR1, partial," the following steps would be necessary:
Retrieve the Pagrus major ESR1 gene sequence from genomic databases (e.g., NCBI GenBank: Pagrus major genome assembly ASM331731v1).
Design primers for amplifying the target domain (e.g., LBD: residues 300–595 in human ESR1).
Use baculovirus or E. coli systems for cost-effective production .
Validate protein folding via circular dichroism (CD) spectroscopy or functional assays (e.g., ligand-binding capacity).
| Assay Type | Purpose |
|---|---|
| Ligand-Binding Assays | Test affinity for estradiol, endocrine disruptors (e.g., BPA) |
| Transcriptional Activity | Measure ER-responsive reporter gene activation in vitro |
The predicted three-dimensional conformation of ER-α from Pagrus major (ESR1_PAGMA) demonstrates approximately 70.71% sequence similarity when compared with homologous structures in protein databases . This level of conservation provides a reliable foundation for structural modeling approaches. When comparing fish estrogen receptors, research indicates significant structural conservation within the DNA-binding domain (DBD) and ligand-binding domain (LBD), especially in species within the Sparidae family .
For researchers conducting structural studies, this conservation allows the application of homology modeling techniques using established templates. The structural analysis should focus particularly on the LBD region, as this contains the binding site for estradiol and other ligands. Methodologically, tools such as AlphaFold DB have proven effective for generating reliable structural predictions that can be further refined through molecular dynamics simulations.
Docking studies reveal significant differences in binding affinities between ER subtypes in fish models. Based on comparative analysis, estradiol (E2) typically shows approximately 28% higher binding affinity with ER-β compared to ER-α . Specifically, docking simulations using AutoDock Vina demonstrate that E2 complexed with ER-β yields binding energies around -8.5 kcal/mol, while ER-α interactions with E2 show binding energies of approximately -6.6 kcal/mol .
Methodologically, researchers should employ multiple complementary approaches:
In silico docking using AutoDock Vina or similar software
Interaction analysis using visualization tools like LigPlot+
Experimental validation through ligand binding assays
The binding interaction analysis reveals that while the number of polar bonds with E2 remains similar between both receptor subtypes, ER-β forms more non-polar bonds with E2, likely accounting for the stronger binding affinity . This distinction is crucial for understanding the differential response of these receptors to endocrine-disrupting compounds in marine environments.
Expression System Comparison:
| System | Advantages | Limitations | Yield | Purification Method |
|---|---|---|---|---|
| E. coli | High yield, cost-effective, rapid expression | Potential for inclusion bodies, limited post-translational modifications | >95% by SDS-PAGE | Affinity chromatography (His-tag) |
| Baculovirus/Insect | Better folding, some post-translational modifications | Moderate yield, more complex setup | 70-85% | Multi-step chromatography |
| Mammalian | Full post-translational modifications, native folding | Low yield, expensive, time-consuming | 50-70% | Complex purification scheme |
For optimal expression in E. coli, researchers should:
Include an N-terminal His-tag for efficient purification
Express the protein at lower temperatures (16-18°C) to enhance solubility
Consider expressing only the LBD or DBD separately for specific applications
Employ buffer systems containing 20mM phosphate buffer with 150mM NaCl at pH 7.2 for optimal stability
For applications requiring full post-translational modifications, mammalian systems may be necessary despite lower yields.
Proper reconstitution and storage are critical for maintaining functional integrity of recombinant ESR1 proteins. Based on established protocols for similar nuclear receptors:
Recommended Reconstitution Protocol:
Centrifuge the lyophilized protein tube before opening to ensure all material is at the bottom
Reconstitute to a concentration of 0.1-0.5 mg/mL using sterile distilled water
Avoid vigorous pipetting or vortexing which can denature the protein
For enhanced stability, add a carrier protein or stabilizer (0.1% BSA, 5% HSA, 10% FBS, or 5% Trehalose)
Allow complete dissolution by gentle rotation at 4°C
Storage Recommendations:
Store lyophilized protein at -20°C to -80°C for up to 1 year
After reconstitution, the protein solution is stable at -20°C for approximately 3 months
For short-term storage (up to 1 week), 2-8°C is acceptable
Aliquot the reconstituted protein solution to minimize freeze-thaw cycles which significantly impact activity
Researchers should validate protein activity after reconstitution using binding assays or reporter gene assays to ensure functional integrity has been maintained.
Mutations in the ligand-binding domain (LBD) of estrogen receptors can significantly alter binding kinetics and activation profiles. While specific data on Pagrus major ESR1 mutations is limited, comparative analysis with human ESR1 mutations provides valuable insights:
Methodological Approach for Mutation Analysis:
Site-directed mutagenesis: Generate equivalent mutations in Pagrus major ESR1 to those observed in human ESR1 (particularly Y537S/N/C and D538G mutations which occur in the LBD)
Binding kinetics assessment: Utilize surface plasmon resonance (SPR) or isothermal titration calorimetry (ITC) to determine:
Association rates (kon)
Dissociation rates (koff)
Equilibrium dissociation constants (KD)
Molecular dynamics simulations: Compare conformational stability between wild-type and mutant receptors
Research on human ESR1 indicates that mutations like Y537S can lead to ligand-independent activation by stabilizing the receptor in an active conformation . Similar structural analysis in Pagrus major ESR1 would determine if comparable mechanisms exist. The high conservation of the LBD suggests that mutations in equivalent positions might produce similar effects, but species-specific differences in protein dynamics may alter the magnitude of these effects.
For researchers studying these mutations, it is crucial to combine in silico modeling with experimental validation using recombinant proteins containing the mutations of interest.
Environmental endocrine disruptors represent a significant concern for marine species, making predictive modeling of their interactions with estrogen receptors essential. Advanced computational approaches for studying these interactions include:
Multi-stage Computational Pipeline:
Molecular docking simulations:
Interaction analysis:
Molecular dynamics (MD) simulations:
Minimum 100ns simulations in explicit solvent
Analysis of binding stability over time
Calculation of MM-GBSA or MM-PBSA for more accurate binding free energies
Quantum mechanics/molecular mechanics (QM/MM):
For detailed electronic structure analysis of key interactions
Particularly valuable for compounds with unusual binding mechanisms
This multi-tiered approach allows researchers to identify potential endocrine disruptors with high confidence and understand their mechanism of action. The binding energy threshold established from estradiol docking (approximately -6.6 kcal/mol for ER-α and -8.5 kcal/mol for ER-β) provides a useful reference point for evaluating the potential potency of environmental compounds .
Understanding the spatiotemporal expression pattern of ESR1 in Pagrus major requires a combination of transcriptomic and proteomic approaches. Based on studies in related teleost species:
Recommended Methodological Approach:
Quantitative RT-PCR:
Design primers specific to Pagrus major ESR1
Use reference genes specific to teleost fish (β-actin, EF1α, and 18S rRNA)
Sample collection across multiple developmental stages and tissues
Calculate relative expression using 2^-ΔΔCt method
RNA-Seq analysis:
Deep sequencing (minimum 30M reads per sample)
Differential expression analysis comparing:
Developmental stages (embryo, larval, juvenile, adult)
Reproductive cycle phases
Different tissue types (liver, gonads, brain, etc.)
In situ hybridization:
Allows spatial localization within tissues
Particularly valuable for brain and gonadal expression patterns
Use DIG-labeled RNA probes specific to ESR1
Immunohistochemistry:
Requires validated antibodies against Pagrus major ESR1
Enables protein-level confirmation of expression patterns
Studies in related species show that ESR expression typically peaks during vitellogenesis in the liver and ovary, with a notable increase and decrease throughout the breeding cycle . This pattern reflects the receptor's critical role in reproductive physiology. For comprehensive analysis, researchers should compare expression patterns of both ER-α and ER-β, as these receptors often show complementary but distinct expression profiles.
The functional characterization of naturally occurring isoforms of Pagrus major ESR1 requires a combination of molecular, cellular, and computational approaches. While specific isoform data for Pagrus major is limited, the methodological approach can be informed by studies of other teleost species:
Experimental Characterization Pipeline:
Isoform identification:
5' and 3' RACE to identify all expressed isoforms
Full-length cloning and sequencing
Analysis of alternative splicing patterns
Domain structure analysis:
Reporter gene assays:
Transfection of each isoform construct into appropriate cell lines
Measurement of basal and ligand-induced transcriptional activity
Determination of EC50 values for estradiol and other ligands
Protein-protein interaction studies:
Co-immunoprecipitation to identify isoform-specific cofactor interactions
Mammalian two-hybrid assays to quantify interaction strengths
ChIP-seq to determine genome-wide binding patterns
The functional differences between isoforms typically center on:
Ligand sensitivity and specificity
Cofactor recruitment profiles
DNA binding preferences
Subcellular localization patterns
Research in other teleost species indicates that alternative splicing often affects the AF-1 domain, resulting in isoforms with differing constitutive activities. Researchers should pay particular attention to expression patterns of these isoforms across tissues, as they may serve tissue-specific functions.
Comparative structural analysis of Pagrus major ESR1 with other teleost species reveals important evolutionary adaptations and functional specializations. Three-dimensional structural comparisons indicate:
Structural Comparison with Related Species:
| Species | Sequence Identity with Pagrus major | RMSD of Cα Chains | Key Structural Differences |
|---|---|---|---|
| Clupea harengus (ER-β) | 76.04% | Not reported | Higher conservation in LBD region |
| Danio rerio (ER-α) | Not specified | Slight differences observed | Minor variations in secondary structure elements |
| Danio rerio (ER-β) | Not specified | 0.244 | High structural conservation |
| Human ESR1 | Not specified | Not reported | Differences primarily in AF-1 domain |
Functional Implications:
Ligand binding properties:
Species-specific variations in binding pocket residues may alter ligand specificity
These differences can affect sensitivity to environmental estrogens
Cofactor interactions:
Variations in the AF-1 and AF-2 domains likely influence cofactor recruitment
Species-specific cofactor interactions may explain differences in transcriptional responses
DNA binding patterns:
While the DBD is highly conserved, subtle differences may alter genomic targeting
ChIP-seq studies would reveal species-specific binding patterns
For comprehensive functional analysis, researchers should combine structural modeling with experimental approaches such as ligand binding assays and transcriptional reporter systems using recombinant receptors from multiple species.
Evolutionary analysis of the ESR1 gene across vertebrate lineages provides valuable insights into the functional adaptation of estrogen signaling. For Pagrus major ESR1, comparative genomic approaches reveal:
Evolutionary Analysis Methodology:
Phylogenetic analysis:
Multiple sequence alignment of ESR1 coding sequences
Construction of maximum likelihood trees
Bayesian inference of evolutionary relationships
Dating of gene duplication events
Selection pressure analysis:
Calculation of dN/dS ratios across different domains
Identification of sites under positive selection
Branch-site tests for lineage-specific selection
Synteny analysis:
Examination of conserved gene neighborhoods
Identification of genomic rearrangements
Inference of ancestral genomic structure
The evolutionary trajectory of ESR1 in teleosts is particularly interesting due to the whole genome duplication event in the teleost lineage, which created additional complexity in estrogen signaling pathways. Research indicates that following this duplication, subfunctionalization and neofunctionalization of estrogen receptors occurred, leading to specialized roles for ER-α and ER-β subtypes .
In Pagrus major, as in other teleosts, the conservation of the LBD suggests strong purifying selection on ligand-binding function, while variations in other domains may reflect adaptations to specific physiological demands or environmental pressures.
For researchers interested in evolutionary aspects, combining sequence analysis with structural modeling and functional assays would provide the most comprehensive understanding of how ESR1 function has evolved across vertebrate lineages.
Recombinant Pagrus major ESR1 offers a species-relevant tool for monitoring endocrine-disrupting compounds (EDCs) in marine environments. Implementing this approach requires:
Methodological Framework for Environmental Monitoring:
In vitro reporter assays:
Stable transfection of Pagrus major ESR1 into appropriate cell lines
Development of luciferase or other reporter systems
Validation with known estrogenic compounds
Creation of standard curves for quantitative analysis
Competitive binding assays:
Development of high-throughput binding assays using recombinant ESR1
Fluorescence polarization or radioligand displacement methods
Screening of environmental samples against estradiol binding
Biosensor development:
Immobilization of recombinant ESR1 on sensor surfaces
Integration with label-free detection systems (SPR, QCM-D)
Field-deployable configurations for in situ monitoring
Validation protocol:
Parallel analysis with chemical methods (LC-MS/MS)
Deployment in gradient-exposure studies
Correlation with biological effects in wild populations
Using recombinant Pagrus major ESR1 provides several advantages over mammalian-based systems for marine monitoring:
Species-relevant sensitivity to environmental contaminants
Temperature adaptations suitable for marine environments
Evolutionary adaptations to marine-specific EDCs
The binding characteristics determined through molecular docking studies (binding energies of approximately -6.6 kcal/mol for ER-α) provide a baseline for comparing potential EDCs . Compounds showing similar or stronger binding energies would warrant further investigation for potential endocrine-disrupting effects.
Structural knowledge of Pagrus major ESR1 enables rational design of species-specific endocrine modulators for potential aquaculture applications. This approach combines:
Design Strategy for Species-Specific Modulators:
Structure-based virtual screening:
Use of the 3D model of Pagrus major ESR1 for in silico screening
Targeting of species-specific binding pocket features
Ranking compounds by predicted binding energy and interaction patterns
Selection of candidates with favorable specificity profiles
Pharmacophore modeling:
Identification of key interaction features from estradiol binding
Development of pharmacophore models specific to Pagrus major ESR1
Screening of compound libraries against these models
Refinement based on experimental validation
Experimental validation pipeline:
Binding assays with recombinant Pagrus major ESR1
Specificity testing against human and other vertebrate ERs
Cell-based transcriptional activation assays
Safety and efficacy testing in controlled aquaculture settings
The docking studies showing differences in binding patterns between ER-α and ER-β (particularly in non-polar interactions) provide valuable starting points for designing subtype-specific modulators . By exploiting these differences, researchers could potentially develop compounds that selectively modulate specific pathways relevant to reproduction or growth in aquaculture settings.
Importantly, all development of such modulators should include comprehensive environmental safety assessments to ensure that any compounds used in aquaculture do not adversely affect wild populations or ecosystems if released.
Researchers frequently encounter expression and solubility challenges when producing recombinant nuclear receptors like ESR1. Based on experiences with similar proteins:
Troubleshooting Strategies:
Optimizing expression constructs:
Express individual domains (LBD, DBD) rather than full-length protein
Use solubility-enhancing tags (MBP, SUMO, Thioredoxin) in addition to His-tag
Optimize codon usage for E. coli expression
Remove flexible regions identified through disorder prediction
Expression condition optimization:
Reduce induction temperature to 16-18°C
Use lower IPTG concentrations (0.1-0.5 mM)
Extend expression time (16-24 hours) at lower temperatures
Screen multiple E. coli strains (BL21(DE3), Rosetta, Arctic Express)
Solubilization strategies:
Purification optimization:
Implement multi-step purification (IMAC followed by ion exchange and size exclusion)
Include ATP wash steps to remove chaperones
Consider on-column refolding protocols
Validate proper folding through circular dichroism or limited proteolysis
Monitoring protein quality at each step using SDS-PAGE and activity assays is essential for optimizing the protocol. For the LBD, including stabilizing ligands during expression and purification can significantly improve yield and quality.
Designing reliable ligand binding assays for recombinant ESR1 requires careful attention to multiple factors:
Critical Assay Design Considerations:
Protein quality control:
Verify structural integrity through circular dichroism
Confirm monomeric status by size exclusion chromatography
Validate functional activity with known ligands
Monitor batch-to-batch consistency
Assay format selection:
Radioligand binding: Highest sensitivity but requires radioactive materials
Fluorescence polarization: Good throughput, no separation steps
Surface plasmon resonance: Real-time kinetics but requires surface immobilization
Isothermal titration calorimetry: Direct thermodynamic parameters but lower throughput
Assay optimization:
Determine optimal protein concentration (typically 10-100 nM)
Establish appropriate incubation times for equilibrium (1-4 hours)
Define optimal temperature (typically 4°C or room temperature)
Include appropriate controls (non-specific binding, solvent effects)
Data analysis recommendations:
Use appropriate binding models (one-site, two-site, cooperative)
Implement global fitting for competition assays
Calculate Z' factor to assess assay quality
Perform technical and biological replicates (minimum n=3)
The docking studies indicating differential binding energies between ER subtypes (-6.6 kcal/mol for ER-α vs -8.5 kcal/mol for ER-β) suggest that assay conditions may need adjustment when working with different receptor subtypes. Researchers should validate assay parameters separately for each receptor to ensure accurate comparative studies.